A Phase 1 Randomized, Double-blind, Placebo-controlled, First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single, Ascending Doses of BMS-986447 in Healthy Adult Participants
The purpose of the study is to evaluate the safety, tolerability and drug levels of single, oral doses of BMS-986447 in healthy participants.
100 项与 BMS-986447 相关的临床结果
100 项与 BMS-986447 相关的转化医学
100 项与 BMS-986447 相关的专利(医药)
100 项与 BMS-986447 相关的药物交易